STOCK TITAN

Ginkgo Bioworks Announces Participation in 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) announced that Co-Founder and CEO Jason Kelly will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 3:45 p.m. Eastern Time. The presentation details, along with a webcast link and replay information, will be available on the company's investor relations website. Ginkgo Bioworks focuses on programming cells for various biotechnology applications, supporting efforts such as COVID-19 testing and vaccine optimization.

Positive
  • Participation in a prestigious healthcare conference enhances visibility and credibility.
  • Focus on diverse biotechnology applications positions the company in multiple markets.
Negative
  • None.

BOSTON, Jan. 5, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that Co-Founder and CEO Jason Kelly is scheduled to participate in a presentation at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022 at 3:45 p.m. Eastern Time.

Further details, a webcast link, and a replay of the presentation will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com  

MEDIA CONTACT:

press@ginkgobioworks.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-40th-annual-jp-morgan-healthcare-conference-301454238.html

SOURCE Ginkgo Bioworks

FAQ

What date will Ginkgo Bioworks present at the J.P. Morgan Healthcare Conference?

Ginkgo Bioworks will present on January 12, 2022.

What time is Ginkgo Bioworks' presentation at the J.P. Morgan Healthcare Conference?

The presentation is scheduled for 3:45 p.m. Eastern Time.

Where can I find the webcast link for Ginkgo Bioworks' presentation?

The webcast link will be posted on Ginkgo Bioworks' investor relations website.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

386.25M
43.10M
6.44%
61.7%
14.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON